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Abstract
Background: Alopecia is the common hair loss problem that can affect many people. However, current therapies for
treatment of alopecia are limited by low efficacy and potentially undesirable side effects. We have identified a new function
for valproic acid (VPA), a GSK3b inhibitor that activates the Wnt/b-catenin pathway, to promote hair re-growth in vitro and in
vivo.
Methodology/ Principal Findings: Topical application of VPA to male C3H mice critically stimulated hair re-growth and
induced terminally differentiated epidermal markers such as filaggrin and loricrin, and the dermal papilla marker alkaline
phosphatase (ALP). VPA induced ALP in human dermal papilla cells by up-regulating the Wnt/b-catenin pathway, whereas
minoxidil (MNX), a drug commonly used to treat alopecia, did not significantly affect the Wnt/b-catenin pathway. VPA
analogs and other GSK3b inhibitors that activate the Wnt/b-catenin pathway such as 4-phenyl butyric acid, LiCl, and BeCl2
also exhibited hair growth-promoting activities in vivo. Importantly, VPA, but not MNX, successfully stimulate hair growth in
the wounds of C3H mice.
Conclusions/ Significance: Our findings indicate that small molecules that activate the Wnt/b-catenin pathway, such as
VPA, can potentially be developed as drugs to stimulate hair re-growth.
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Introduction
Alopecia causes serious problems for numerous people in the
world. However, current therapies for the treatment of alopecia
are limited by low efficacy and potentially undesirable side effects
caused by application of available drugs [1]. The Wnt/b-catenin
pathway is important for several developmental processes,
including hair follicle development [2–4]. Activation of the
Wnt/b-catenin pathway is required for initiation of hair follicle
formation [5], and stimulates growth and differentiation of hair by
maintaining expression of genes that function at the anagen phase
of the hair cycle [6]. Wnt3a and Wnt7a maintain dermal papillae
in anagen phase as inductive signals for hair growth [6]. In
addition, b-catenin accumulates in the nuclei of dermal papillae
during anagen, and provides growth signals for hair follicle
progenitors [7,8]. Finally, the Wnt/b-catenin pathway plays a role
in the differentiation of stem cells into hair follicular keratinocytes
[9]. Together, these findings indicate that the Wnt/b-catenin
pathway could be an ideal target for the development of drugs that
activate hair growth by inducing anagen phase genes. Unfortu-
nately, there are currently no known drugs that stimulate hair
growth by targeting the Wnt/b-catenin pathway.
Valproic acid (VPA; 2-propyl-pentanoic acid) is a mood
stabilizer commonly prescribed for the treatment of epilepsy and
bipolar disorders over the last several decades [10,11]. VPA is
known as a histone deacetylase inhibitor that exerts its effects
through modification of chromatin structure and gene expression
[12,13]. VPA is also known to affect several different signaling
pathways including protein kinase C, extracellular signal-regulated
kinase (ERK), and Wnt/b-catenin pathways [14–16]. VPA
activates the Wnt/b-catenin pathway by inhibiting GSK3b
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4[17,18], leading to axonal remodeling, synaptic protein clustering,
and differentiation of neuronal progenitors [19,20].
We investigated the effect of VPA on the hair re-growth of C3H
mice by considering the relationship between the Wnt/b-catenin
pathway and hair formation. VPA induced hair re-growth as
efficiently as MNX and activated the Wnt/b-catenin pathway in
vivo. The potential importance of VPA in human hair re-growth
was indicated by the increased expression of ALP and activation of
the Wnt/b-catenin pathway following treatment of VPA in human
dermal papilla cells. Alkaline phosphatase (ALP), a prominent
dermal papilla marker [21–23], was identified as a critical marker
for hair growth promotion. The role of the Wnt/b-catenin
pathway in the regulation of ALP activity was further investigated
by testing VPA analogs and other Wnt activators in vivo and in vitro.
Finally, we further characterized specific roles of VPA in induced
hair growth in the wounds of C3H mice. These VPA effects
accompanying the activation of keratin 15 and CD34 stem cell
markers also correlate with the Wnt/b-catenin pathway and ALP
activities.
Materials and Methods
Reagents
VPA, 4-phenyl butyric acid (PBA), and 2-ethyl butyric acid
(EBA) were purchased from Acros. Lithium chloride (LiCl) and
beryllium chloride (BeCl2) were purchased from Sigma, and MNX
was purchased from Daejung.
Animals and in Vivo Hair Growth Test
Six-wk-old male C3H mice were purchased from Orient Bio
Co., and allowed to adapt to their new environment for 1 wk. The
hairs on the backs of 7-wk-old mice, whose hair follicles were in
telogen phase, were shaved with a hair clipper and 300 ml of each
drug at an appropriate concentration (as described in figure
legends) was applied topically daily for up to 28 d. All reagents
used for the hair re-growth test were dissolved in a vehicle
composed of 50% (vol/vol) ethanol, 30% water, and 20%
propylene glycol. TOP-GAL transgenic mice carrying the lac Z
reporter gene downstream of the c-fos promoter that responds to
the lymphoid enhancer binding factor 1/transcription factor 3
(LEF/TCF) mediated signaling pathway and activated b-catenin
were purchased from the Jackson Laboratory. Genotyping was
confirmed by standard polymerase chain reaction (PCR) using the
following primers: transgene forward 59-ATCCTCTGCATGGT-
CAGGTC-39, transgene reverse 59-CGTGGCCTGATTCATT-
CC-39; internal positive control forward 59-CAAATGTTG-
CTTGTCTGGTG-39, internal positive control reverse 59-
GTCAGTCGAGTGCACAGTTT-39. All animal procedures
were approved by the Institutional Review Board of Severance
Hospital, Yonsei University College of Medicine (09-013).
Quantitative Histomorphometry
Hair cycle stages were evaluated and classified as described [24]
by the means of quantitative histomorphometry. Histomorphom-
ety was performed with hematoxylin and eosin (H&E)-stained
sections that were taken from defined back skin regions. At least 50
hair follicles per mouse per group were evaluated.
Cell Culture
Human dermal papilla cells were obtained from Dr. Jin-Ho
Jung in the Department of Dermatology at Seoul National
University, and maintained in Dulbecco9s Modified Eagle
Medium (DMEM) containing 10% (vol/vol) fetal bovine serum
(FBS) and supplemented with 0.1 mg/ml G418 (Gibco-BRL).
Cells were plated at a density of 6610
5 cells per 10-cm diameter
dish.
Western Blotting Analysis
Cells or tissue that was ground in mortars were lysed in RIPA
buffer (150 mM NaCl, 10 mM Tris, pH 7.2, 0.1% sodium
dodecyl sulfate (SDS), 1.0% Triton X-100, 1% sodium deoxycho-
late, 5 mM EDTA). Samples were separated on 10–12% SDS
polyacrylamide gels and transferred onto a PROTRANHnitrocel-
lulose membrane (Schleicher and Schuell Co.). After blocking in
phosphate buffered saline (PBS) containing 5% non-fat dry skim
milk and 0.07% (vol/vol) Tween 20, the blots were incubated with
the following primary antibodies overnight at 4uC: anti-b-catenin
(Santa Cruz Biotechnology, 1:1000), p-Erk (Santa Cruz Biotech-
nology, 1:1000), p-Akt (Santa Cruz Biotechnology, 1:1000),
fillagrin (Covance, Berkeley, CA, 1:1000), loricrin (Covance,
1:1000), keratin 14 (Covance, 1:1000), a-tubulin (Oncogene
Research Products, 1:5000), PCNA (proliferating-cell nuclear
antigen, Santa Cruz Biotechnology, 1:500), BMP4 (R&D systems,
1:500), and ALP (Abcam, 1:100). Horseradish peroxidase-
conjugated anti-mouse (Cell Signaling) and anti-rabbit (Bio-Rad)
antibodies were used as secondary antibodies. The signals were
detected by enhanced chemiluminescence (Amersham Bioscience)
using a luminescent image analyzer, LAS-3000 (Fujifilm).
Reverse Transcription (RT)-PCR
Total RNA was prepared using TRIzol reagent (Invitrogen) and
cDNA was synthesized in vitro using M-MLV reverse transcriptase
(Invitrogen).PCRwasperformedwithTaqDNApolymeraseusinga
System2700(AppliedBiosystems)at94uCfor5 min,followedby25–
30 cyclesof94uCfor30 sec,55–60uCfor1 min,and72uCfor1 min.
The PCR products were electrophoresed on agarose gels and
photographedusingaLAS-3000analyzer.Thefollowingprimersets
were used: filaggrin, forward 59-GCTTAAATGCATCTCCAG-39
andreverse59-AGTCAGTCCTATTGCAGG-39;loricrin,forward
59-CCTACCTGGCCGTGCAAG-39 and reverse 59-CATGA-
GAAAGTTAAGCCCATCG-39;keratin14,forward 59-GGACG-
CCCACCTTTCATCTTC -39 and reverse 59- ATCTGGCG-
GTTGGTG GAGG-39; GAPDH, forward 59-ACCACAGTC-
CATGCCATCAC-39 and reverse 59-TCCACCACCCTGTT-
GCTGTA-39; BMP4, forward 59-AGCAGCCAAACTATGG-
GCTA-39 and reverse 59-TGGTTGAGTTGAGGTGGTCA-39;
BMP6,forward59-AACCAACCACGCGATTGTG-59andreverse
59-AAGTCTCATCGTCCCACCTC-39; and ALP, forward 59-
CAAACCGAGATACAAGCACTCCC-39 and reverse59-CGAA-
GAGACCCAATAGGTAGTCCAC-39.
Immunohistochemistry
Skin tissues were fixed overnight in 4% paraformaldehyde.
Paraffin sections (4-mM thick) were deparaffinized and rehydrated.
For antigen retrieval, the slides were autoclaved in 10 mM sodium
citrate buffer. Sections were pre-incubated in PBS and then
blocked in PBS containing 5% bovine serum albumin and 1%
goat serum at room temperature for 30 min. The sections were
incubated overnight at 4uC with the following dilutions of primary
antibodies: anti-b-catenin (BD transduction laboratory, 1:100), p-
Erk (Cell Signaling, 1:30), p-Akt (Santa Cruz, 1:50), PCNA (Santa
Cruz, 1:500), filaggrin (Covance, 1:500), loricrin (Covance, 1:500),
keratin 14 (Covance, 1:500), BMP4 (R&D systems, 1:50), Keratin
15 (Thermo Scientific, CA, 1:200), CD34 (Abcam, 1:30), nestin
(BD Bioscience, 1:200), Ki67 (Abcam, 1:500), and keratin 17
(Abcam, 1:100). The sections were rinsed with PBS and incubated
with Alexa Fluor 488- or Alexa Fluor 555-conjugated IgG
secondary antibody (Molecular Probes, 1:400) at room tempera-
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phenylindole, Boehringer Mannheim, 1:5000). The fluorescent
signals were visualized on a LSM510 META confocal microscope
(Carl Zeiss).
Alkaline Phosphatase Staining
Human dermal papilla cells were plated in 12-well plates at
7.5610
4 cells per well. After growth for 24 h, cells were treated
with drugs for 72 h, and then fixed in 4% paraformaldehyde for
10 min and washed with PBS. For optimal staining, cells were
rinsed in TN buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). Cells
were incubated in 120 mg/ml 4-nitroblue tetrazolium and 60 mg/
ml BCIP (5-bromo-4-chloro-3-indolylphophate) in TN buffer for
30 min. The reaction was stopped by washing with PBS, and the
cells were examined under a bright field microscope. Dark blue
staining indicates positive signal for ALP. For ALP staining of
tissues, 10-mM cryosections were incubated with BCIP and
analyzed as above. ALP activity was measured at 405 nm by
FLUOstar OPTIMA luminometer.
X-gal Staining of Tissues
Fresh skin tissue was fixed in 4% paraformaldehyde overnight
and then embedded in Tissue Tek O.C.T. compound (Sakura
Finetechnical). Cryosections (10-mM) were prepared on coated
slides and used for X-gal (5-Bromo-4-chloro-3-indolyl-b-D-galac-
topyranoside, Gold BioTechnology) staining. The sections were
fixed with 0.2% glutaraldehyde for 5 min, washed with PBS for
5 min, and incubated in 1 mg/ml X-gal solution for 24 h at room
temperature in a humid environment. The slides were then
washed for 5 min with PBS, rinsed with distilled water, and
counterstained with Nuclear Fast Red for 5 min.
Results
Valproic Acid Promotes Hair Re-Growth and Induces
Terminally Differentiated Hair Markers in Vivo
We tested the hair re-growth activity of LiCl and VPA, two
chemical activators of the Wnt/b-catenin pathway [25,26]. VPA or
LiCl was topically applied daily onto the backs of C3H mice at
different concentrations to determine the optimal concentration for
Figure 1. Effects of VPA and MNX on hair re-growth, hair cycle stage in mouse skin. The back skin of 7-wk-old male C3H mice was shaved
and treated daily with topical application of vehicle, 500 mM valproic acid (VPA), or 100 mM minoxidil (MNX) for 28 d. (A) Gross images showing hair
re-growth in C3H mice treated with VPA or MNX for 28 d (upper panel) and H&E staining of the VPA or MNX-treated skin for 28 d (lower panel). (B)
Quantitative histomorphometic analyses of skin tissues treated with VPA or MNX for 28 d were performed with 5 mice for each group; Early anagen,
anagen I-anagen II; Middle anagen, anagen III-IV; Late anagen, anagen V-anagen VI; Early catagen, catagen I-catagen III; Middle catagen, catagen IV-V;
Late catagen, catagen VI-catagen VIII. Asterisks denote significant differences between control and test groups as measured by t-test with one
asterisk being p,0.05, two asterisks being p,0.005, and three asterisks being p,0.0001. Original magnification: A, 6100 (H&E staining).
doi:10.1371/journal.pone.0034152.g001
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mice treated with 1 M LiCl or 500 mM VPA showed hair growth
phenotypes (Figures S1A and S1B). Especially, VPA promoted hair
re-growth as efficiently as MNX after 28 d (Figure 1A). The hair
follicles of mice treated with VPA or MNX entered anagen phase,
whereashairfolliclesinthecontrolgrouptreatedwithvehiclesolution
remained in telogen phase (Figure 1A, data for different drug
treatmenttimesareshowninFigureS2A).Thehistomorphometrical
analyses showed that VPA promoted telogen-anagen transition
(Figure 1B). Especially, the hair follicles of mice treated with VPA
were transformed to middle- or late-anagen (Figure 1B). Immuno-
histochemical analysis confirmed that expression of filaggrin and
loricrinwasincreasedbyVPAorMNX(Figure2A,datafordifferent
drugtreatmenttimesareshowninFiguresS2BandS2C).Wedidnot
observe any significant abnormal phenotypes in the epidermis, hair
follicles, or other skin structures aside from hair re-growth following
applicationofVPAorMNX(Figure1A).Incontrasttotheepidermis
of mouse skin treated with VPA, skin that was treated with LiCl
revealed critical abnormal changes including an increase in the
thickness of the epidermis(Figure S3), whereexpression of filaggrin,
loricrin, and keratin 14 was also abnormally elevated as shown by
immunohistochemistry (Figure S3).
Valproic Acid Activates the Wnt/b-Catenin Pathway in
Addition to the Erk and Akt Pathways
The expression of b-catenin in mouse skin was significantly
increased by application of VPA, but only slightly increased by
MNX (Figure 2A). MNX is known to promote hair re-growth via
the Erk and Akt pathways, which are involved in the regulation of
proliferation in dermal papilla cells of the hair follicle [27].
Interestingly, the activities of both Erk and Akt were similarly
enhanced by treatment with either VPA or MNX (Figure 2A). The
expression level of the proliferation marker PCNA was increased
by application of VPA or MNX compared to control skin
(Figure 2A). Thus, VPA up-regulates the Wnt/b-catenin pathway
in addition to the Erk and Akt pathways, but via a different
mechanism.
To examine the short-term effects of VPA on hair re-growth, we
analyzedtheskinofC3HmiceafterapplicationofVPAorMNXfor
7 d.Thethicknessoftheepidermisincreasedslightlyandthenumber
Figure 2. Effects of VPA and MNX on epidermal differentiation markers, ALP activities, and hair follicular stem cell markers. The
back skin of 7-wk-old male C3H mice was shaved and treated daily with topical application of vehicle, 500 mM valproic acid (VPA), or 100 mM
minoxidil (MNX) for 7 d or 28 d. (A) Immunohistochemical analysis of epidermis of C3H mice treated with VPA or MNX for 28 d with antibody against
b-catenin, filaggrin, loricrin, keratin 14, p-Erk, p-Akt, or PCNA. (B) Immunohistochemical analysis of b-catenin expression in hair follicles (upper panel)
and ALP staining (lower panel) of skin treated with vehicle, VPA, or MNX for 7 d. Dark blue region in the dermal papillae of hair follicles (a red arrow in
middle panel) represent positivity for ALP activity. (C) Immunohistochemical analysis was performed with anti-keratin 15, or -CD34 antibody. Original
magnification: A, 6635; B, 6635 (immunohistochemistry) and 6400 (ALP staining); C, 6635.
doi:10.1371/journal.pone.0034152.g002
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(Figure S4A, upper panel). Immunohistochemical analysis showed
thatkeratin14expressionwasincreasedfollowinga7 dapplicationof
VPA or MNX (Figure S4A, lower panel), although the level of
keratin14 was not changed 28 d application of VPA or MNX
(Figure2A).Interestingly,VPA,butnotMNX,greatlyincreasedthe
expression ofb-catenininthe hairfollicles ofC3Hmice(Figure2B).
We also observed significant induction of ALP in the dermal papilla
following application of VPA, but not MNX (Figures 2B and S4B).
Moreover, we confirmed specific activation of the Wnt/b-catenin
pathway in the pre-cortex regions [4] of the skin of TOP-Gal Wnt
reportermicetreatedfor7 dwithVPA,butnotMNX(FigureS4C).
Interestingly, Keratin 15 and CD34, the hair follicular stem cell
markers, were induced in bulge cells by application of VPA for 7 d
(Figure 2C), butnot byapplication ofMNX.
Valproic Acid, but not MNX, Up-Regulates the Wnt/b-
Catenin Pathway and ALP Activity in Human Dermal
Papilla Cells
ToidentifywhetherVPAcanactivatetheWnt/b-cateninpathway
inhumansystems,weusedaninvitroculturesystemofhumandermal
papilla cells.The expression level of b-catenin was greatly increased
bytreatmentwithVPA,butnotMNXfor72 h(Figures3AandS5).
Similarly,expressionofbothBMP4andALPwasincreasedbyVPA,
but not MNX (Figures 3A and S5). We also confirmed significant
activation of b-catenin and BMP4 in human dermal papilla cells
treatedwithVPAbyimmunocytochemistry,andagainthosechanges
were not observed following treatment with MNX (Figure 3B). To
evaluatetheeffectofVPAorMNXontheregulationofALPactivity,
we used human dermal papilla cells at passage 11 that showed very
weakALPactivity.WeobservedasignificantincreaseinALPactivity
followingtreatmentwithVPA,butnotMNX(Figure3C).Moreover,
theinductionofALPactivitybyVPAwasblockedbynoggin,aBMP4
antagonist (Figure 3D). To confirm the role of the Wnt/b-catenin
pathwayintheactivationofALP,wemeasuredtheeffectsofWnt3a,
BMP4,orepidermalgrowthfactor(EGF)ligandonALP.Expression
of both ALP and b-catenin was significantly increased by treatment
with Wnt3a or BMP4 in a concentration-dependent manner,
whereas these changes were not significantly induced by treatment
withEGF(Figure3E).Thespecific activationofALPbyWnt3aand
BMP wasalsoconfirmed by adirect enzyme assay (Figure 3F).
Activators of the Wnt/b-Catenin Pathway Promote Hair
Re-Growth in Vivo
To confirm the role of the Wnt/b-catenin pathway in hair re-
growth, we tested the effects of drugs that regulate the Wnt/b-
Figure 3. Effects of VPA and MNX on the activation status of the Wnt/b-catenin pathway and ALP activity in human dermal papilla
cells. Human dermal papilla cells at passage 11 with minimal ALP activity were used to test the ability of VPA and MNX to recover ALP activity. Cells
were grown in DMEM supplemented with 10% heat-inactivated FBS, G418 (100 mg/ml), streptomycin (100 mg/ml), and penicillin G sodium (100 mg/
ml) in 5% CO2 at 37uC, and treated with 1 mM VPA or 100 mM MNX for 72 h. (A) Western blotting for b-catenin, BMP4, ALP and a-tubulin. (B)
Immunocytochemical staining with antibody against b-catenin or BMP4. (C) ALP staining. Cell morphology (left panels) was examined under a bright-
field microscope. Dark blue staining indicates ALP-expressing cells (right panels). (D) Western blotting for b-catenin, BMP4, ALP, and a-tubulin in
human dermal papilla cells treated with VPA or noggin (500 ng/ml). (E) Western blotting for b-catenin, BMP4, ALP, and a-tubulin expression in human
dermal papilla cells treated with Wnt3a (200 or 40 ng/ml), BMP4 (100 or 20 ng/ml), or EGF (100 or 20 ng/ml) for 72 h. (F) ALP activity was measured as
described in Methods after treatment with Wnt3a (200 ng/ml), BMP4 (100 ng/ml), or EGF (100 ng/ml) for 72 h. Asterisks denote significant
differences between control and test group as measured by t-test with one asterisk being p,0.05 and two asterisks being p,0.005. Original
magnification: B, 6635; C, 6100.
doi:10.1371/journal.pone.0034152.g003
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(BeCl2), LiCl (an alternative GSK3b inhibitor), and several
derivatives of VPA including 4-phenyl butyric acid (PBA) and 2-
ethyl butyric acid (EBA) were tested for their effects on hair re-
growth. PBA or EBA induced hair re-growth after topical
application to the back of C3H mice for 28 d (Figure 4A, first
row panel). The levels of b-catenin were increased by treatment
with PBA, but not EBA (Figure 4A, second row panel). The hair
follicles of skin tissues treated with PBA or EBA entered anagen
phase as shown by H&E staining (Figure 4A, third row panel).
Histomorphometrical analysis revealed that PBA and EBA also
induced telogen-anagen transition (Figure 4B). LiCl or BeCl2 also
induced hair re-growth after 35 d although its hair growing
activity was mild (Figure S6A, first row panel). Treatment with
LiCl or BeCl2 increased the levels of b-catenin and accelerated
hair cycle into the anagen phase (Figure S6A, second row panel
and third row panel). However, the thickness of the epidermis was
increased in skin treated with BeCl2 or PBA compared to control
skin, as previously described for LiCl application. The expression
of filaggrin and loricrin was abnormally increased by application
of BeCl2, similar to the effect of LiCl (Figure S6B). However, the
activities of Erk and Akt were increased by treatment with all of
the drugs, including EBA (Figures S6C and S7).
ALP activity was increased by treatment with VPA or PBA,
which also up-regulated the Wnt/b-catenin pathway in human
dermal papilla (Figure 5A). Interestingly, treatment with EBA,
which did not affect the Wnt/b-catenin pathway, did not
significantly increase ALP activity (Figure 5A). In addition, the
protein and mRNA levels of ALP were increased following
treatment with VPA or PBA, which also increased the protein level
of b-catenin, but not by treatment with MNX or EBA (Figures 5B,
5C, and S8). Expression of BMP4 mRNA was increased by
treatment with VPA, but was only marginally increased by
treatment with MNX or PBA and was not induced at all by EBA.
Expression of BMP6, which induces the most pronounced effects
on ALP activation among the BMPs [28], was markedly increased
by either VPA or PBA but not by MNX or EBA (Figure 5C). The
specific activation of ALP by VPA or PBA was also confirmed by a
direct enzyme assay (Figure 5D). The mouse model showed similar
phenotypes to those observed in human dermal papilla cells; the
levels of b-catenin in the epidermis and ALP in dermal papillae
were significantly increased by application of VPA or PBA for 7 d,
Figure 4. Effects of Wnt/b-catenin pathway activators on hair re-growth on mouse skin. The vehicle, 500 mM VPA, 100 mM MNX or
derivatives of VPA (500 mM PBA, 500 mM EBA) were topically applied to shaved back skin of C3H mice daily for 28 d. (A) Gross images of hair re-
growth (first row panel), immunohistochemistry of the drug-treated skin with antibody against b-catenin (second row panel), and H&E staining of the
drug-treated skin (third row panel). (B) Quantitative histomorphometric analyses were performed for 5 mice for each group. Asterisks denote
significant differences between control and test group as measured by t-test with one asterisks being p,0.05, two asterisks being p,0.005, and
three asterisks being p,0.0001. Original magnification: A, 6100 (H&E staining) and 6635 (immunohistochemistry).
doi:10.1371/journal.pone.0034152.g004
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S9A and S9B).
Valproic Acid Promotes Hair Growth in Cutaneous
Wounds in Mice
Activation of the Wnt/b-catenin pathway in epidermal
keratinocytes can potentially induce hair growth in mouse skin
that is damaged by wounding [29]. To test the effectiveness of
VPA on wound-induced hair growth, we daily applied VPA to the
wound area (diameter=0.5 mm) of C3H mice. The presence of
epithelial stem cells in hair follicles around wound areas induces
spontaneous hair cycling as previously reported [30], and VPA
further significantly enhanced hair growth (Figures 6A and S10A)
and the transition from telogen phase to anagen phase at the
wound site as revealed by histological analysis (Figure 6B). The
expression levels of fillaggrin, loricrin, and keratin 14 in wounds
was also specifically increased by application of VPA for 14 d by
both immunoblot and immunohistochemical analyses (Figures 6C
and 6D). Moreover, VPA specifically activated the Wnt/b-catenin
pathway during hair growth at wound sites, as shown by increased
b-catenin expression (Figures 6C and 6D) and induction of b-
galactosidase in newly formed hair follicles of TOP-Gal Wnt
reporter mice (Figure S10B; representative mice hairg growth
phenotypes by drug application are shown in Figure S10C).
Importantly, we also observed an increase in ALP activity in the
hair follicles following application of VPA (Figure 6E). Keratin 15
and CD34, the hair follicular stem cell markers, were increased
after 25 d of VPA application to the wounds (Figure 6F).
Discussion
VPA is an antiepileptic drug frequently prescribed due to its
safety and effectiveness [10,11]. Prolonged use of VPA resulted in
several side effects including hair loss by oral intake; these adverse
effects are attributed to zinc and biotinidase depletion [31]. We
did not observe hair re-growth effects when VPA was orally
administered to C57BL/6 mice (Figures S11A and S11B).
However, topical application of VPA significantly promoted hair
formation in murine models. The levels of b-catenin in the mice
skin were specifically increased by topical application of VPA
(Figure S11C).
In this study, we demonstrated that GSK3b inhibitors that
activate the Wnt/b-catenin pathway [17,18,25,32] could poten-
tially be developed as drugs to treat hair loss and baldness
involving defects in hair follicles. Among these, VPA was identified
as the most potent hair re-growth factor without causing skin
abnormalities in mice. Alternative inhibitors of GSK3b, LiCl or
BeCl2, also stimulated hair re-growth and returned the hair cycle
to the anagen phase, but abnormally increased the thickness of the
epidermis with hyper-activation of terminally differentiated
epidermal markers. In contrast to the epidermis of mouse skin
treated with other GSK3b inhibitor, skin of C3H mice treated
with VPA didn’t reveal any significant abnormal phenotypes in the
epidermis. We found that ALP is a highly credible marker for
activation of the Wnt/b-catenin pathway, and importance of the
Wnt/b-catenin pathway in the activation of ALP was confirmed
by the demonstration that ALP was not regulated by MNX or
EBA, which did not induce expression of b-catenin and BMP4. It
is known that VPA stimulates neuronal differentiation of neural
progenitors through the induction of BMP4 [33,34], and the effect
Figure 5. Effects of Wnt/b-catenin pathway activators on the regulation of BMP and alkaline phosphatase activity. Human dermal
papilla cells at passage 11 with minimal ALP activity were used to test the ability to recover ALP activity. (A) Morphology (upper panels) and ALP
staining patterns (lower panels) of human dermal papilla cells treated with 1 mM VPA, 1 mM PBA, 1mM EBA. Cells were observed under bright-field.
(B) Western blotting for b-catenin, ALP, or a-tubulin expression in extracts prepared from drug-treated human dermal papilla cells. (C) RT-PCR analysis
of BMP4, BMP6, ALP, and GAPDH expression using total RNA prepared from drug-treated human dermal papilla cells. (D) ALP activity. Asterisks
denote significant differences between control and test group as measured by t-test with one asterisk being p,0.05, two asterisks being p,0.005.
Original magnification: B, 6100.
doi:10.1371/journal.pone.0034152.g005
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[28]. Our study reporting that BMP4 plays a role as an activator of
ALP further confirms the importance of the Wnt/b-catenin
pathway in hair re-growth.
Although the relative effect was small compared to VPA or
PBA, EBA (which did not activate b-catenin and BMP4 or ALP),
still induced hair formation. These results indicate that the hair-
inducing activity of EBA may be independent of the Wnt/b-
catenin pathway, and in fact we confirmed that EBA induced
activation of Erk and Akt, which are in turn involved in
keratinocyte proliferation. Interestingly, VPA induced expression
of the hair follicular stem cell markers ketatin 15 and CD34 during
hair formation and wound-induced growth. VPA is known to
induce CD34 expression and enhance stemness [35,36]. The bald
scalps of men with androgenetic alopecia lack CD200-rich, CD34-
positive hair follicle progenitor cells, and have a defect in
conversion of hair follicle stem cells to progenitor cells, which
play a role in the pathogenesis of androgenetic alopecia [37]. The
results of our study indicate that small molecules that activate the
Wnt/b-catenin pathway, such as VPA, can potentially be applied
for the development of drugs to accelerate hair cycle and stimulate
hair re-growth.
Supporting Information
Figure S1 Hair re-growth following topical application
of LiCl, VPA, or MNX to the mice skin. Back skin of 8-wk-
old male C3H mice were shaved, vehicle or various concentrations
of LiCl, VPA, or MNX were applied topically for 35 d. (A) Gross
images of mice treated with LiCl, VPA, or MNX. (B) Enlarged
images of representative skin from Figure S1A.
(TIF)
Figure S2 Effects of VPA or MNX on b-catenin, epider-
mal differentiation, and proliferation markers in mouse
skin. C3H mice were treated with VPA or MNX for 7, 14, or
21 d. H&E staining and immunohistochemical analyses were
performed as described in Figure 1 and 2. Original magnification:
H&E, 6200; immunohistochemistry, 6635.
(TIF)
Figure S3 Effects of LiCl on epidermal differentiation
markers, b-catenin, PCNA, and activities of Erk and Akt
Figure 6. Effects of VPA or MNX on wound-induced hair growth. Four full-thickness excisions (0.2 cm
2 circular wounds) of skin were made on
the backs of 8-wk-old C3H or TOP-Gal transgenic mice, and 500 mM VPA or 100 mM MNX was topically applied daily to the wounds. (A) Gross images
of representative wounded back skin of C3H mice 25 d after drug application. (B) H&E staining of wounded skin treated with VPA or MNX. (C, D)
Western blot (C) and Immunohistochemical (D) analyses of b-catenin, filaggrin, loricrin and keratin 14 in the wounds. (E) Wounded skins were treated
with vehicle, VPA, or MNX for 14 d, and tissue was subjected to ALP staining assays. (F) Immunohistochemical analysis was performed with anti-
keratin 15, or -CD34 antibody. Original magnification: B, 6200; C, 6635; D, 6200; E, 6200; F, 6635.
doi:10.1371/journal.pone.0034152.g006
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subjected to H&E staining, ALP staining, or immunohistochemical
analysis to detect filaggrin, loricrin, keratin14, b-catenin, p-Erk, p-
Akt, and PCNA as described in Figures 1 and 2. Original
magnification: H&E, 6100; immunohistochemistry, 6635; ALP
staining, 6200.
(TIF)
Figure S4 Effects of VPA or MNX on expression of
keratin14, ALP or b-galactosidase activities monitoring
the Wnt/b-catenin activities in mice skin. C3H mice were
treated with VPA or MNX for 7 d. (A) H&E staining (upper panel)
and immunohistochemical analysis for keratin 14 (lower panel) in
treated skin. (B) ALP staining of control, VPA- or MNX-treated
mice skin. (C) TOP-GAL transgenic mice tissues treated with
vehicle, VPA, or MNX for 7 d were subjected to the X-gal
staining to examine regulation of the Wnt/b-catenin pathway.
Blue region of hair follicles represent positive Wnt/b-catenin
signaling. Original magnification: A,6100; B,6200; C,6400 (left
panel) and 6200 (right panel).
(TIF)
Figure S5 Effects of VPA and MNX on the activation
status of the Wnt/b-catenin pathway and ALP in human
dermal papilla cells. Human dermal papilla cells were grown
in DMEM supplemented with 10% heat-inactivated FBS and
were treated with 1 mM VPA or 100 mM MNX for 72 h. Western
blotting was performed in VPA or MNX-treated human dermal
papilla cells. The relative expression of each protein such as b-
catenin, BMP4, and ALP was calculated as the ratio of each
protein expression level to a-tubulin level. The software used for
the quantification was Multi-Gauge V 3.0 (Fujifilm). Asterisks
denote significant differences between control and test groups as
measured by t-test with one asterik being p,0.05, two asteriks
being p,0.005, and three asteriks being p,0.0001.
(TIF)
Figure S6 Effects of Wnt/b-catenin pathway activators
on hair re-growth in mouse skin. The back skin of C3H mice
was shaved and treated with topical application of vehicle,
alternative GSK3b inhibitor (1 M LiCl, 200 mM BeCl2) daily
for 35 d. (A) Gross images of hair re-growth (first row panel),
immunohistochemistry of LiCl or BeCl2-treated skin with antibody
against b-catenin (second row panel), and H&E staining of LiCl or
BeCl2-treated skin (third row panel). (B) Immunohistochemical
analysis for filaggrin, loricrin, and keratin14 in LiCl or BeCl2-
treated skin. (C) Immunohistochemical analysis for p-Erk and p-
Akt in LiCl or BeCl2-treated skin. Original magnification: A,6100
(H&E staining) and 6400 (immunohistochemistry); B, 6635; C,
6635.
(TIF)
Figure S7 Effects of VPA, MNX and derivatives of VPA
on epidermal differentiation markers on mouse skin.
The back skin of C3H mice was shaved and treated with topical
application of the vehicle, 500 mM VPA, 100 Mm MNX, or
derivatives of VPA (500 mM PBA, 500 mM EBA) daily for 28 d.
Immunohistochemical analysis for filaggrin, loricrin, keratin14, b-
catenin, p-Erk, p-Akt, and PCNA in the drug-treated skin.
Original magnification: 6635.
(TIF)
Figure S8 Effects of Wnt/b-catenin pathway activators
on the activation status of the Wnt/b-catenin pathway
and ALP in human dermal papilla cells. Human dermal
papilla cells were treated with 1 mM VPA, 100 mM MNX, 1 mM
PBA, or 1 mM EBA for 72 h. The relative expression of b-catenin
or ALP was calculated as the ratio of each protein level to a-
tubulin level. The software used for the quantification was Multi-
Gauge V 3.0 (Fujifilm). Asterisks denote the significant differences
between control and test groups as measured by t-test with one
asterisk being p,0.05, two asterisks being p,0.005, and three
asterisks being p,0.0001.
(TIF)
Figure S9 Effects of VPA, MNX, PBA, and EBA on the
activation of Wnt/b-catenin pathway, ALP activity in
vivo. After topical application of 500 mM VPA, 100 mM MNX,
500 mM PBA, or 500 mM EBA onto the backs of C3H mice for
7 d, the skin tissue was excised from the treated area for
immunohistochemistry and ALP staining. (A) Immunohistochem-
ical staining for b-catenin or keratin 14. (B) Immunohistochemical
analysis for b-catenin (upper panel) and ALP staining (lower panel)
of hair follicles of skin treated with vehicle, VPA, MNX, PBA, or
EBA. Dark blue regions in the dermal papilla of hair follicles (red
arrows) represent positive staining for ALP activity. Original
magnification: A, 6635; B, 6635 (immunohistochemistry) and
6400 (ALP staining).
(TIF)
Figure S10 Effects of VPA and MNX on wound-induced
hair growth and activation of the Wnt/b-catenin signal-
ing in vivo. Four full-thickness skin excisions (0.2 cm
2 circular
wounds) were made on the backs of 8-wk-old C3H mice, and
500 mM VPA or 100 mM MNX was topically applied daily. (A)
Gross images of the wounded back skin of C3H mice 25 d after
application of drugs. Right panels are magnified representative
images. (B) Wounded skins in TOP-GAL transgenic mice were
treated with vehicle, VPA, or MNX for 14 d, and tissue was
subjected to X-gal staining. (C) Gross images of the wounded back
skin of TOP-gal mice 14 d after application of drugs. Original
magnification: B, 6200.
(TIF)
Figure S11 Effects of VPA or MNX by oral administra-
tion on hair re-growth. (A) Gross images of C57BL/6 mice
orally administered by VPA or MNX. The back skin of C57BL/
6 mice was shaved and VPA or MNX was orally administered at a
dose of 200 mg/kg for 35 d. (B) H&E staining of mice skin orally
administered or topically applied by VPA. VPA was orally
administered at a dose of 200 mg/kg or topically applied at
500 mM for 35 d. (C) Immunohistochemical analysis for b-
catenin, filaggirn, loricrin, and keratin14 in mice skin orally or
topically applied by VPA. Original magnification: B, 6100; C,
6635.
(TIF)
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